Osimertinib versus Durvalumab versus observation after chemoradiation in unresectable EGFR-mutant NSCLC

Saved in:
Bibliographic Details
Main Authors: Zhao, Binghao (Author) , Yao, Longping (Author) , Ma, Wenbin (Author)
Format: Article (Journal) Editorial
Language:English
Published: May 2024
In: Journal of thoracic oncology
Year: 2024, Volume: 19, Issue: 5, Pages: e5-e6
ISSN:1556-1380
DOI:10.1016/j.jtho.2024.01.020
Online Access:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.jtho.2024.01.020
Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S1556086424000613
Get full text
Author Notes:Binghao Zhao, Longping Yao, Wenbin Ma
Description
Item Description:Online verfügbar: 6. Mai 2024
Gesehen am 25.11.2024
Physical Description:Online Resource
ISSN:1556-1380
DOI:10.1016/j.jtho.2024.01.020